BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32023488)

  • 1. Novel multiparticulate pH triggered delayed release chronotherapeutic drug delivery of celecoxib-β-cyclodextrin inclusion complexes by using Box-Behnken design.
    Maqbool I; Akhtar M; Ahmad R; Sadaquat H; Noreen S; Batool A; Khan SU
    Eur J Pharm Sci; 2020 Apr; 146():105254. PubMed ID: 32023488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removing Control of Cyclodextrin-Drug Complexes Using High Affinity Molecule.
    Kim YH; Kim ST; Jee JP; Kim DY; Kang D; Kim K; Park SY; Sim T; Cho KH; Jang DJ
    J Nanosci Nanotechnol; 2018 Feb; 18(2):898-901. PubMed ID: 29448513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes.
    Sinha VR; Anitha R; Ghosh S; Amita ; Kumria R; Bhinge JR; Kumar M
    Acta Pharm; 2007 Mar; 57(1):47-60. PubMed ID: 19839406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin.
    Karanje RV; Bhavsar YV; Jahagirdar KH; Bhise KS
    AAPS PharmSciTech; 2013 Jun; 14(2):639-48. PubMed ID: 23516110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.
    Sarfraz RM; Ahmad M; Mahmood A; Akram MR; Abrar A
    Drug Des Devel Ther; 2017; 11():3083-3096. PubMed ID: 29123380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
    Jain SK; Gupta Y; Jain A; Amin S
    Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery.
    Jain SK; Gupta Y; Jain A; Bhola M
    Drug Deliv; 2007 Aug; 14(6):327-35. PubMed ID: 17701522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cyclodextrin-based nasal delivery system for lorazepam.
    Jug M; Bećirević-Laćan M
    Drug Dev Ind Pharm; 2008 Aug; 34(8):817-26. PubMed ID: 18622800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
    Ghorab DM; Amin MM; Khowessah OM; Tadros MI
    Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
    Ramasamy T; Ruttala HB; Shanmugam S; Umadevi SK
    Drug Deliv; 2013 Feb; 20(2):65-77. PubMed ID: 23537465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.
    Lopedota A; Cutrignelli A; Laquintana V; Denora N; Iacobazzi RM; Perrone M; Fanizza E; Mastrodonato M; Mentino D; Lopalco A; Depalo N; Franco M
    Pharm Res; 2016 Sep; 33(9):2195-208. PubMed ID: 27245467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FORMULATION AND IN VITRO EVALUATION OF ACYCLOVIR LOADED POLYMERIC MICROPARTICLES: A SOLUBILITY ENHANCEMENT STUDY.
    Mahmood A; Ahmad M; Sarfraz RM; Minhas MU; Yaqoob A
    Acta Pol Pharm; 2016 Sep; 73(5):1311-1324. PubMed ID: 29638071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of microparticles of β-cyclodextrin/glutathione and chitosan/glutathione obtained by spray-drying.
    Webber V; de Siqueira Ferreira D; Barreto PLM; Weiss-Angeli V; Vanderlinde R
    Food Res Int; 2018 Mar; 105():432-439. PubMed ID: 29433233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.
    Lakshmi K; Reddy MP; Kaza R
    Curr Drug Discov Technol; 2013 Dec; 10(4):305-14. PubMed ID: 24074306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.